QLT diversifies with Atrix acquisition
Article Abstract:
QLT Inc. revealed a $751-million (U.S.) deal by acquiring Atrix Laboratories Inc. of Colorado to expand its product pipeline, to diversify beyond its flagship Visudyne anti-blindness drug, which is expected to boost QLT revenue. The transaction offer value is approximately $855-million and the transaction value net of Atrix's cash is $751-million.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Western may sell assets to pay off debts
Article Abstract:
The asset selling plans of Western Forest Products Ltd., which is attributed to company's dismal performance in second quarter revenues, are examined.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: OSC unveils litany of Yorkton accusations. OSC reiterates tough stand on disclosure. OSC investigates Yorkton
- Abstracts: CGI sets sights on major acquisitions. Corel set to unveil corporate plan. Corel plans for profit within six months
- Abstracts: Barrington fights bid with poison pill. Oil giants team up in huge heavy oil project. Calgary braces for big battle over Big Oil
- Abstracts: Ranger CEO challenges Petrobank. Petrocan to sell stake in venture near Norway
- Abstracts: DataMirror shares fall on earnings shortfall. The Microsoft decision: Internet strategy hits speed bump. U.S. endorses Kasten Chase product